Jefferies Group LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$7,413,724
-30.5%
7,347,000
-27.2%
0.06%
-30.3%
Q2 2022$10,674,524
+36.4%
10,096,000
+45.7%
0.09%
+81.6%
Q1 2022$7,825,787
+117.3%
6,927,000
+113.5%
0.05%
+133.3%
Q4 2021$3,602,103
-6.6%
3,245,0000.0%0.02%
-25.0%
Q3 2021$3,856,677
+0.8%
3,245,000
+0.1%
0.03%
+16.7%
Q2 2021$3,825,238
-34.3%
3,242,000
-37.9%
0.02%
-52.9%
Q1 2021$5,823,079
+61.4%
5,218,000
+62.2%
0.05%
+82.1%
Q4 2020$3,607,891
+12.8%
3,218,000
-0.5%
0.03%
-20.0%
Q3 2020$3,198,0003,233,0000.04%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Wellesley Asset Management 12,388$12,458,0000.88%
SHENKMAN CAPITAL MANAGEMENT INC 13,818,000$13,900,0000.78%
ABSOLUTE INVESTMENT ADVISERS, LLC 3,500,000$3,510,0000.62%
WOLVERINE ASSET MANAGEMENT LLC 28,655,000$28,803,0000.31%
TENOR CAPITAL MANAGEMENT Co., L.P. 12,334,000$12,434,0000.28%
CSS LLC/IL 5,000,000$5,024,0000.24%
CAPSTONE INVESTMENT ADVISORS, LLC 22,700,000$22,913,0000.14%
Jefferies Group LLC 7,347,000$7,413,7240.06%
FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. 26,000$26,0000.04%
Calamos Advisors LLC 7,500,000$7,542,0000.03%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders